Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Revenue

Verrica Pharmaceuticals had revenue of $5.02M in the quarter ending March 31, 2026, with 46.06% growth. This brings the company's revenue in the last twelve months to $37.16M, up 417.63% year-over-year. In the year 2025, Verrica Pharmaceuticals had annual revenue of $35.58M with 370.22% growth.

• Revenue (ttm): $37.16M
• Revenue Growth: +417.63%
• P/S Ratio: 3.21
• Revenue / Employee: $488,961
• Employees: 76
• Market Cap: 107.71M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.58M	28.01M	370.22%
Dec 31, 2024	7.57M	2.44M	47.66%
Dec 31, 2023	5.12M	-3.91M	-43.27%
Dec 31, 2022	9.03M	-2.97M	-24.73%
Dec 31, 2021	12.00M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error